<code id='68C3DAF534'></code><style id='68C3DAF534'></style>
    • <acronym id='68C3DAF534'></acronym>
      <center id='68C3DAF534'><center id='68C3DAF534'><tfoot id='68C3DAF534'></tfoot></center><abbr id='68C3DAF534'><dir id='68C3DAF534'><tfoot id='68C3DAF534'></tfoot><noframes id='68C3DAF534'>

    • <optgroup id='68C3DAF534'><strike id='68C3DAF534'><sup id='68C3DAF534'></sup></strike><code id='68C3DAF534'></code></optgroup>
        1. <b id='68C3DAF534'><label id='68C3DAF534'><select id='68C3DAF534'><dt id='68C3DAF534'><span id='68C3DAF534'></span></dt></select></label></b><u id='68C3DAF534'></u>
          <i id='68C3DAF534'><strike id='68C3DAF534'><tt id='68C3DAF534'><pre id='68C3DAF534'></pre></tt></strike></i>

          leisure time

          leisure time

          author:hotspot    Page View:8599
          Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT
          Adobe

          Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

          The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

          advertisement

          The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Morphosys mixed study results for blood cancer drug
          Morphosys mixed study results for blood cancer drug

          AdobeLONDON—AnexperimentalbloodcancerdrugfromMorphoSyshititsprimarytargetinapivotaltrial,thecompanya

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Readout Newsletter: The latest at Gilead, Catalent, and the NIH

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb